Evidence map›Paper›PMID 41464695›Full record

ArticleJournal of clinical medicine2025

Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group.

Andreas A Argyriou, Emmanouil V Dermitzakis, Maria Chondrogianni, Aikaterini Foska, Dimitrios Rikos, Panagiotis Soldatos, Michail Vikelis, Greek Research Alliance for the Study of Headache and Pain (GRASP) Study Group

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andreas A ArgyriouHeadache Outpatient Clinic, Department of Neurology, Agios Andreas State General Hospital of Patras, 26335 Patras, Greece.ORCID 0000-0003-2131-7114
Emmanouil V DermitzakisGeneral Clinic Thessaloniki, 54645 Thessaloniki, Greece.ORCID 0000-0001-9275-0076
Maria ChondrogianniSecond Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, 'Attikon' University Hospital, 12462 Athens, Greece.ORCID 0000-0002-8315-5846
Aikaterini FoskaSecond Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, 'Attikon' University Hospital, 12462 Athens, Greece.
Dimitrios Rikos404 Military Hospital, 41222 Larisa, Greece.ORCID 0000-0003-2346-5057
Panagiotis SoldatosIndependent Researcher, 24100 Kalamata, Greece.
Michail VikelisGlyfada Headache Clinic, 16675 Athens, Greece.ORCID 0000-0002-2715-7898
Greek Research Alliance for the Study of Headache and Pain (GRASP) Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

early preventioneptinezumabhigh-frequency chronic migraine

Identifiers

PMID41464695
PMCPMC12733432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.